Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2536 to 2550 of 9009 results

  1. Sacituzumab tirumotecan for treating advanced or metastatic gastric, gastro-oesophageal junction or oesophageal adenocarcinoma after 2 or more treatment lines [ID6723]

    Awaiting development Reference number: GID-TA11932 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  2. Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA)

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. NeuroSAFE for Intra-operative frozen section evaluation of neurovascular bundle adjacent prostate capsule during radical prostatectomy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Orbital atherectomy for calcified coronary artery disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Multi-vessel minimal access coronary artery surgery for multi-vessel coronary artery disease

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Nivolumab with ipilimumab for untreated advanced hepatocellular carcinoma [ID6239]

    In development Reference number: GID-TA11116 Expected publication date:  11 November 2026

    Technology appraisal guidance
    In development

  7. Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110]

    In development Reference number: GID-TA11023 Expected publication date: TBC

    Technology appraisal guidance
    In development

  8. Botulinum toxin injection to cricopharyngeal muscle for retrograde cricopharyngeal dysfunction (RCPD)

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  9. Thermocoagulation for the treatment of piles and anal fistula

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  10. Parathyroid autofluorescence and parathyroid angiography

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  11. Vedolizumab for treating moderately to severely active ulcerative colitis in people 2 to 17 years [TSID12134]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  12. Ustekinumab for treating moderately to severely active ulcerative colitis in children aged 2 to 17 years [TSID 12128]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  13. Cyanoacrylate glue for hernia mesh fixation (MT707)

    Topic prioritisation

    Medical technologies guidance
    Topic prioritisation

  14. Diltiazem (Anatop, SLV-324, VEN 307) for Anal fissure [TSID 12100]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation

  15. Teduglutide for treating short bowel syndrome in babies 4 to 12 months [TSID10755]

    Topic prioritisation

    Technology appraisal guidance
    Topic prioritisation